Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study

Marina Talamonti, Marco Galluzzo, Andrea Chiricozzi, Pietro Quaglino, Gabriella Fabbrocini, Paolo Gisondi, Angelo Valerio Marzano, Concetta Potenza, Andrea Conti, Aurora Parodi, Stefano Piaserico, Federico Bardazzi, Giuseppe Argenziano, Franco Rongioletti, Luca Stingeni, Giuseppe Micali, Francesco Loconsole, Maria Teresa Rossi, Maria Rita Bongiorno, Claudio FelicianiPietro Rubegni, Paolo Amerio, Maria Concetta Fargnoli, Paolo Pigatto, Paola Savoia, Steven Paul Nisticò, Sandra Giustini, Andrea Carugno, Serafinella Patrizia Cannavo’, Giulia Rech, Francesca Prignano, Annamaria Offidani, Maurizio Lombardo, Iris Zalaudek, Luca Bianchi, Ketty Peris

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds